A Study of Solbinsiran (LY3561774) in Participants With Severe Hypertriglyceridemia

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(40 sites)

United States

Axsendo Clinical Research - Peak Heart & Vascular - Phoenix, Phoenix, Arizona

Synexus Clinical Research US, Inc./Orange Grove Family Practice, Tucson, Arizona

National Heart Institute, Beverly Hills, California

Ark Clinical Research, Long Beach, California

Catalina Research Institute, LLC, Montclair, California